SET Nuclear Oncogene (SET) (N-Term) Peptide
SET
Reactivité: Humain
Hôte: Synthetic
BP, IHC, WB, IP
-
- Antigène Tous les produits SET/TAF-I (SET)
- SET/TAF-I (SET) (SET Nuclear Oncogene (SET))
- Protein Region
- N-Term
- Origine
- Humain
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB), Immunoprecipitation (IP)
- Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-SET antibody (Catalog #: ARP56542_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Antigène
- SET/TAF-I (SET) (SET Nuclear Oncogene (SET))
- Synonymes
- 2PP2A Peptide, I2PP2A Peptide, IGAAD Peptide, IPP2A2 Peptide, PHAPII Peptide, TAF-I Peptide, TAF-IBETA Peptide, 2610030F17Rik Peptide, 5730420M11Rik Peptide, AA407739 Peptide, I-2PP2A Peptide, StF-IT-1 Peptide, 2pp2a Peptide, i2pp2a Peptide, igaad Peptide, ipp2a2 Peptide, phapii Peptide, set Peptide, set-a Peptide, set-b Peptide, taf-ibeta Peptide, wu:fb30g11 Peptide, wu:fd16c08 Peptide, SET nuclear proto-oncogene Peptide, SET nuclear oncogene Peptide, SET translocation Peptide, SET nuclear proto-oncogene L homeolog Peptide, SET nuclear proto-oncogene b Peptide, SET Peptide, Set Peptide, LOC403555 Peptide, set.L Peptide, setb Peptide
- Sujet
-
SET is a multitasking protein, involved in apoptosis, transcription, nucleosome assembly and histone binding. Isoform 2 anti-apoptotic activity is mediated by inhibition of the GZMA-activated DNase, NME1. In the course of cytotoxic T-lymphocyte (CTL)-indu
Alias Symbols: 2PP2A, I2PP2A, IGAAD, PHAPII, TAF-IBETA, TAF-I, IPP2A2
Protein Interaction Partner: ANP32A,APEX1,CDK5,CDK5R1,CDKN1A,ELAVL1,EP300,GZMA,HIST2H4A,HIST3H3,HMGB2,KLF5,MLL,NME1,PPP2CA,PPP2R1B,PTMA,RAC1,SET,SETBP1,SGOL1,TAF1A,THAP7,ANP32A,APEX1,CDK5R1,CDKN1A,DGKE,GZMA,HIST3H3,HIST4H4,HMGB2,KLF5,MEPCE,NME1,OTUD5,RGS20,SETBP1,TAF1A,THAP7,USP17L2,USP46,WDR48
Protein Size: 277 - Poids moléculaire
- 32 kDa
- ID gène
- 6418
- NCBI Accession
- NM_003011, NP_003002
- UniProt
- B2RCX0
-
Vous êtes ici:
